Home Investment Memo: 526237

Investment Memo: 526237

[s2If !current_user_can(access_s2member_level1)][lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

Our Rating: HOLD

Mehabe score: 6
G Factor: 6
Piotski Score: 6
The stock has a rating HOLD. The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 6 and Piotski score of 6.

Description

Morgan Ventures is also engaged in power generation from windmills.Site: 526237

Market Cap: Rs 13.6 cr Price: 13.7 Trading pe: 9.29x
Book-value: 37.8/share Div yield: 0.00 % Earning yield: 14.19%
Face-value: 10.0/share 52week high: 14.63 52week low: 5.00

Technical Analysis

  • Stock trades at 13.7, above its 50dma 11.26. It also trades above its 200dma 9.52. The stock remains bullish on techicals
  • The 52 week high is at 14.63 and the 52week low is at 5.00

Price Chart

P/E Chart

Sales and Margin

Strengths

– Stock is trading at 0.36 times its book value

Weakness

– has a low return on equity of -0.81% for last 3 years.

Competition

– The industry trades at a mean P/E of 21.7x. SBI Cards trades at the industry’s max P/E of 89.25x. 526237 trades at a P/E of 9.29x
– Industry’s mean G-Factor is 4.6 while the mean Piotski score is 7.0. 526237 has a G-Factor of 6 and Piotski scoreof 6.
– Average 1 month return for industry is 3.9%. The max 1- month return was given by Muthoot Finance: a return of 16.62 %

Quarterly Results

  • Sales for period ended Mar 2021 is Rs 1.07 cr compared to Rs 0.99 cr for period ended Mar 2020, a rise of 8.1%
  • Operating Profits reported at Rs 0.94 cr for period ended Mar 2021 vis-vis 0.9 for period ended Mar 2020 .
  • Operating Margins contracted -305.9 bps for period ended Mar 2021 vis-vis Mar 2020 .
  • The EPS for Mar 2021 was Rs -0.95 compared to Rs 0.77 for previous quarter ended Dec 2020 and Rs -0.07 for Mar 2020

Profit & Loss Statement

Profit&Loss Comments

  • Company reported sales of Rs 5.81 cr for period ended Mar 2021 vis-vis sales of Rs 1.16 cr for the period ended Mar 2020, a healthy growth of 80.0%. The 3 year sales cagr stood at 734.4%.
  • Operating margins expanded to 94.84% for period ended Mar 2021 vis-vis 76.72% for period ended Mar 2020, expansion of 1812.0 bps.
  • Net Profit reported at Rs 1.46 cr for period ended Mar 2021 vis-vis sales of Rs -0.1 cr for the period ended Mar 2020, rising 106.8%.
  • Company recorded a healthy Net Profit CAGR of 426.6% over the last 3 years

Balance Sheet Statement

Cash Flow Statement

Cash Flow comments

    Sales Growth

    Profit Growth Statement

    Profit Growth Statement

    Stock Price CAGR

    Return of Equity

    General Comments

    – The company has improved its Return on Equity (RoE) metric. The RoE on Last Year basis was 4.0% compared to -1.0% over the last 3 Years.
    – The stock has given a return of 151% on a 1 Year basis vis-vis a return of 1% over the last 3 Years.
    – The compounded sales growth on a TTM bassis is 401% vis-vis a compounded sales growth of 734% over the last 3 Years.
    – The compounded profit growth on a TTM basis is 1560% vis-vis a compounded profit growth of 427% over the last 3 Years.

    Ratios

    Shareholding Pattern

    – Public shareholding has remained largely constant. The Mar 2021 public holding stood at 25.2% vis-vis 25.2% for Dec 2020

    Conclusion

    – Stock is trading at 0.36 times its book value – has a low return on equity of -0.81% for last 3 years.

    • The business fundamentals of the stock remain stable. Stronger near term results will build interest in the stock. We suggest to wait for a upturn in business performance.
    • Technically, the stock remains above its 50 DMA 11.26 and is trading at 13.7, thus bullish price action wise.
    • Thus, overall we retain a HOLD on the stock.

    [/s2If]
    Join Our Telegram Group